Table 1.
Clinicopathological parameters | Number of cases | HER-2 positive rate, n (%) | χ2 value | P value | |
Gender | Male | 97 | 17 (17.53) | 0.405 | 0.525 |
Female | 65 | 14 (21.54) | |||
Age | ≥ 60 | 74 | 15 (20.27) | 0.113 | 0.736 |
< 60 | 88 | 16 (18.19) | |||
Tumor location | Colon | 76 | 17 (22.37) | 0.967 | 0.326 |
Rectum | 86 | 14 (16.28) | |||
Tumor size/cm | ≥ 5 | 99 | 20 (20.20) | 0.187 | 0.665 |
< 5 | 63 | 11 (17.46) | |||
Dukes staging | |||||
A + B | 84 | 12 (14.29) | 6.861 | 0.009 | |
C + D | 68 | 19 (27.94) | |||
Degree of differentiation | Well-differentiated | 30 | 6 (20.00) | 4.631 | 0.099 |
Moderately differentiated | 54 | 15 (27.78) | |||
Poorly differentiated | 78 | 10 (12.82) | |||
Lymph node metastasis | With | 86 | 22 (25.58) | 4.922 | 0.027 |
Without | 76 | 9 (11.84) | |||
Depth of invasion | Serosa | 101 | 14 (13.86) | 4.822 | 0.028 |
Muscular layer | 61 | 17 (27.87) |
HER-2: Human epidermal growth factor receptor.